Synthroid and Anesthesia: What Every Woman Needs to Know Before Surgery

Why Your Anesthesiologist Needs to Know About Levothyroxine

Tell your anesthesia team about levothyroxine before any procedure. This sounds routine, but many women forget to list thyroid medication on pre-op drug lists, especially when it feels as background as a daily vitamin. The interaction between thyroid status and anesthetic agents is meaningful, and the risks scale directly with how well or poorly your thyroid is controlled at the time of surgery.

What Levothyroxine Does in Your Body

Levothyroxine is a synthetic form of thyroxine (T4), the primary thyroid hormone your body produces. Once absorbed, T4 is converted peripherally to the active triiodothyronine (T3), which governs heart rate, cardiac output, oxygen consumption, body temperature regulation, and the speed at which your liver metabolizes other drugs, including anesthetic agents. Thyroid hormone physiology is reviewed in detail by the American Thyroid Association.

When thyroid hormone levels are low, every one of those functions slows down. When they are high, they accelerate. Both states carry specific perioperative hazards that your anesthesiologist needs to plan around.

How Common Is This for Women?

Women are diagnosed with hypothyroidism at roughly 5 to 8 times the rate of men, with prevalence rising sharply after age 40. In the United States, approximately 4.6% of the population aged 12 and older has hypothyroidism, and the large majority are women. Levothyroxine has ranked as the number-one or number-two most dispensed prescription drug in the U.S. For over a decade, which means millions of women are presenting for surgery on this medication every year.

The Specific Anesthesia Risks in Women With Hypothyroidism

Poorly controlled hypothyroidism creates a cascade of physiological changes that make anesthesia more complicated. Mild, well-treated hypothyroidism with a normal TSH carries very little additional risk.

Hemodynamic Instability

Low thyroid hormone reduces cardiac contractility and heart rate while increasing systemic vascular resistance. Intraoperatively, this translates to a higher likelihood of hypotension and bradycardia when volatile anesthetic agents are introduced. A 2014 review in Anesthesiology found that patients with overt hypothyroidism (TSH above 10 mIU/L) undergoing non-cardiac surgery had significantly greater rates of intraoperative hemodynamic instability compared to euthyroid controls.

Slowed Drug Metabolism

Thyroid hormone is a key regulator of hepatic cytochrome P450 enzyme activity. In hypothyroid states, drug clearance slows. This means the standard doses of opioids, benzodiazepines, and propofol may produce deeper and longer sedation than anticipated. Women are already known to wake from anesthesia faster than men in some studies, but this advantage is blunted in hypothyroidism. Your anesthesiologist may need to reduce initial doses and titrate more carefully.

Hypothermia and Thermoregulation

The operating room is cold. Women already lose body heat faster than men of equivalent mass, partly due to body composition differences. Hypothyroid patients have impaired thermogenesis, which compounds this. Post-operative hypothermia prolongs recovery room stays and increases cardiac stress. Your team should know to monitor your temperature aggressively.

Myxedema Coma: Rare but Real

Severe, unrecognized hypothyroidism can progress to myxedema crisis under the physiological stress of surgery. This is rare. Still, it is worth naming, because it underscores why elective surgeries should be postponed until TSH is within the normal range. The American Association of Clinical Endocrinologists advises postponing elective surgery when TSH exceeds 10 mIU/L until euthyroid status is achieved.

What Happens If Your Thyroid Is Overreplaced (Hyperthyroid State)

The other direction matters too. Women on levothyroxine who are taking slightly too much medication can have a suppressed TSH and elevated free T4, a subclinically hyperthyroid state. Perioperatively, this raises the risk of:

• Tachycardia and cardiac arrhythmias under anesthesia, particularly atrial fibrillation
• Exaggerated hemodynamic response to surgical stress
• Thyroid storm in rare cases of unrecognized overt hyperthyroidism

If your most recent TSH was flagged as low before your surgery date, bring that lab result to your pre-operative appointment. Do not adjust your own dose without speaking to your prescriber first.

Perioperative Dosing: Should You Take Levothyroxine the Morning of Surgery?

Yes, in most cases. Take your usual dose with a very small sip of water, even on a nil-by-mouth morning. This is explicitly supported by guidance from multiple anesthesiology and endocrinology bodies. The reasoning is straightforward: levothyroxine has a mean serum half-life of approximately 6 to 7 days in euthyroid adults, and a single missed dose will not produce a meaningful drop in circulating thyroid hormone within 24 hours.

What If You Miss the Dose Anyway?

Missing one dose the morning of surgery is not a crisis. The long half-life means circulating T4 levels fall by only a fraction over 24 hours. If you are having a major procedure with expected multi-day NPO status afterward, your clinical team should arrange intravenous levothyroxine (IV T4) to bridge the gap. IV levothyroxine is dosed at approximately 50 to 75% of your oral daily dose due to the difference in bioavailability, as described in the Synthroid prescribing information.

What About Absorption Interactions Before Surgery?

If you take levothyroxine with any of the following, absorption is impaired and your circulating T4 levels may be lower than expected going into surgery:

• Calcium carbonate antacids (separate by at least 4 hours)
• Proton pump inhibitors (reduce T4 absorption by up to 30%)
• Iron supplements (take at least 4 hours apart)
• High-fiber meals immediately after dosing

Women on calcium supplements for bone health, which is a large fraction of women over 40, need to confirm they are spacing calcium and levothyroxine correctly before a surgery where pre-operative thyroid status matters.

Sex-Specific Physiology: How Hormonal Status Changes the Picture

Thyroid physiology in women is not static. It shifts across the menstrual cycle, through pregnancy, during perimenopause, and into the post-menopausal years. These shifts matter when you are being assessed for surgical fitness.

Reproductive Years and the Menstrual Cycle

Estrogen increases thyroid-binding globulin (TBG), the protein that carries T4 in the blood. Higher TBG means more T4 is bound and unavailable. Women on oral contraceptives or estrogen therapy who are also on levothyroxine may need higher levothyroxine doses to maintain euthyroid status. If you are going in for surgery and recently started or changed your OCP or hormone therapy, ask your prescriber to recheck your TSH before the procedure.

Perimenopause

Estrogen levels become erratic in perimenopause, fluctuating widely from month to month. This directly destabilizes TBG levels and, by extension, free T4 and TSH. Perimenopausal women are also at higher baseline risk for thyroid autoimmunity. A TSH that was normal 12 months ago may not reflect current thyroid status. Have your TSH checked within 3 months of any elective surgery if you are in perimenopause.

Post-Menopause

In post-menopause, estrogen is low and stable. Women who are not on hormone therapy typically need less levothyroxine than they did during their reproductive years. This means there is a higher relative risk of over-replacement and a suppressed TSH in this group. Pre-operative labs should include a TSH specifically to rule out inadvertent hyperthyroid state before surgery.

Pregnancy, Lactation, and Contraception

Levothyroxine is one of the few drugs that is explicitly required rather than avoided during pregnancy in women with hypothyroidism. The framing changes completely compared to other drug-surgery articles.

Pregnancy Safety

Levothyroxine is FDA Pregnancy Category A, meaning controlled studies show no fetal risk. It is not just safe during pregnancy, it is essential. Untreated maternal hypothyroidism is associated with miscarriage, placental abruption, preterm birth, and impaired fetal neurodevelopment. A large observational study published in NEJM showed that children born to mothers with untreated hypothyroidism during pregnancy had significantly lower IQ scores.

Dose requirements increase by 25 to 50% during pregnancy, often beginning in the first trimester. If you are pregnant and scheduled for a procedure requiring anesthesia, your obstetric and endocrine teams must coordinate. The goal TSH in pregnancy is lower than in non-pregnant women: ACOG and the American Thyroid Association recommend trimester-specific targets, generally TSH below 2.5 mIU/L in the first trimester.

Perioperative Risk in Pregnancy

Surgery under general anesthesia during pregnancy carries additional risks beyond thyroid status, including fetal exposure to anesthetic agents and the risk of preterm labor. Non-urgent surgery is generally deferred to the second trimester when possible. If you are on levothyroxine and pregnant, your surgical team needs to know both facts. Uncontrolled hypothyroidism in a pregnant woman going to the OR is a combination that requires obstetric and anesthesiology collaboration.

Lactation

Levothyroxine transfers into breast milk, but at levels that are physiologically negligible for the infant. It is compatible with breastfeeding and is not a reason to stop nursing. If you are pumping and dumping after anesthesia for any reason, that decision is about the anesthetic agents, not about levothyroxine.

Contraception

Levothyroxine is not a teratogen and does not require contraception for its own sake. However, if your thyroid disease is inadequately controlled, fertility is impaired, making contraception planning a different but related conversation. Oral contraceptives, as noted above, can increase TBG and change your levothyroxine dose requirement.

Can You Drink Alcohol on Synthroid?

Alcohol does not have a documented pharmacokinetic interaction with levothyroxine. It does not block absorption, alter protein binding, or directly interfere with T4-to-T3 conversion in the way that, say, calcium or iron does.

The relevant concern is indirect. Heavy alcohol use is associated with liver disease, and the liver is where most peripheral T4-to-T3 conversion happens. Chronic liver disease can therefore impair thyroid hormone activation and make hypothyroidism harder to manage. Around the time of surgery specifically, alcohol can increase bleeding risk, impair immune recovery, and worsen the hemodynamic instability that hypothyroid patients are already prone to.

The practical answer: an occasional glass of wine does not meaningfully interact with levothyroxine. Drinking heavily in the days before or after surgery is a separate problem with its own anesthetic risks, and you should disclose alcohol use to your surgical team regardless of what medications you take.

Who Is at Higher Risk Perioperatively: A Life-Stage Guide

Not every woman on levothyroxine faces the same risk profile going into surgery. The following breakdown addresses who needs extra pre-operative attention.

Higher Risk: Likely Needs TSH Check and Possible Dose Adjustment Before Surgery

• Women with TSH above 10 mIU/L or below 0.1 mIU/L at last check
• Pregnant women at any trimester (TSH targets are tighter)
• Women who recently changed their OCP, hormone therapy, or started a new absorption-interfering drug
• Women with Hashimoto's thyroiditis whose TSH fluctuates even on stable dosing
• Perimenopausal women with no TSH in the past 6 to 12 months
• Women planning cardiac surgery (thyroid status has amplified hemodynamic implications)

Lower Risk: Likely Can Proceed With Standard Pre-Op Counseling

• Women with a confirmed normal TSH within the past 3 months on a stable dose
• Women undergoing minor procedures with local or regional anesthesia only
• Women who take levothyroxine correctly with no absorption-disrupting drugs

Female-Relevant Conditions to Flag

Women with the following conditions overlap heavily with the levothyroxine-taking population and may have additional considerations:

• PCOS: Autoimmune thyroiditis occurs at higher rates in women with PCOS. Studies show thyroid antibody prevalence of up to 27% in women with PCOS compared to roughly 8% in the general female population. Pre-operative thyroid function testing is especially warranted.
• Postpartum thyroiditis: Women in the postpartum period may be in a hypothyroid or hyperthyroid phase of postpartum thyroiditis, which is distinct from pre-existing hypothyroidism and can change surgical risk.
• Osteoporosis: Long-term over-replacement with levothyroxine (suppressed TSH) is a recognized risk factor for bone loss in post-menopausal women. If you are on a TSH-suppressive dose for thyroid cancer, your anesthesiologist should know your cardiovascular risk profile accordingly.
• Female pattern hair loss and hormonal acne: Both can be symptoms of thyroid disease and signal that thyroid status may not be optimally controlled, even if TSH is technically within range.

What to Tell Your Surgical Team: A Pre-Op Checklist

Before your procedure, gather the following and bring it to your pre-operative appointment:

1. Your current levothyroxine dose (in micrograms, not milligrams) and brand versus generic status
2. Your most recent TSH result, including the date it was drawn
3. Any other medications that interact with levothyroxine absorption (calcium, iron, PPIs, cholestyramine)
4. Your hormonal status: Are you on oral contraceptives, hormone therapy, or currently pregnant?
5. Any history of thyroid cancer, because TSH-suppressive therapy carries specific cardiovascular implications for the anesthesiologist
6. Recent symptoms of thyroid imbalance: unusual fatigue, palpitations, heat or cold intolerance, or unexplained weight change

"The thyroid status of a woman presenting for surgery is not a box-checking exercise. A TSH of 8 mIU/L in a perimenopausal woman on an unchanged dose for five years should prompt a delay, not a waiver," says Dr. Elena Vasquez, MD, WomanRx medical reviewer and women's health specialist.

A Note on the Evidence Gap

Women are the majority of levothyroxine users, yet the landmark perioperative trials on thyroid disease and anesthesia, including the studies most commonly cited in anesthesiology textbooks, enrolled predominantly or entirely male-majority cohorts or did not stratify by sex. The 2014 meta-analysis in Anesthesiology that informed current practice guidance did not report sex-disaggregated outcomes.

What this means for you: the dose-response relationships between hypothyroid severity and anesthetic risk are extrapolated to women rather than directly studied in female-specific populations. The hemodynamic effects of hypothyroidism in perimenopausal women, who face concurrent declines in estrogen-mediated cardiovascular protection, have not been formally characterized in a prospective trial. Your clinical team is working from general physiology principles and case-series data when they make decisions for you specifically. This is not a reason to panic. It is a reason to make sure your TSH is well-controlled and your care team has your complete hormonal picture before any elective procedure.

Other Drug Interactions to Know Around the Time of Surgery

Surgery often introduces new medications: antibiotics, NSAIDs, anticoagulants, anti-emetics, and post-operative pain drugs. Some of these interact with levothyroxine.

• Ketamine: Can cause sympathomimetic stimulation that is amplified in hyperthyroid patients. Your anesthesiologist may avoid it if your TSH is suppressed.
• Amiodarone: Sometimes used for intraoperative arrhythmias. It is iodine-rich and directly disrupts thyroid hormone synthesis and conversion. Amiodarone can induce either hypothyroidism or hyperthyroidism and should be flagged in any patient with pre-existing thyroid disease.
• Corticosteroids: Used commonly for post-operative nausea, airway inflammation, or pain. High-dose corticosteroids transiently suppress TSH and reduce T4-to-T3 conversion, which can briefly obscure thyroid status on post-operative labs.
• Sucralfate and aluminum-containing antacids: Sometimes given post-operatively. These impair levothyroxine absorption and should be spaced by at least 4 hours if you resume oral levothyroxine while still in hospital.

Review your complete medication list, including any drugs added perioperatively, with your prescribing clinician before restarting your home regimen.